Source: Abstract. Conference titles: International Congress of Pharmaceutical Sciences (CIFARP). Unidades: FMRP, FCFRP
Subjects: NEOPLASIAS MAMÁRIAS, NEFRITE, LÚPUS ERITEMATOSO SISTÊMICO
ABNT
FERNANDES, Bruno José Dumet et al. Determination of cyclophosphamide enantiomers in plasma by lc-ms/ms: application to pharmacokinetics in breast cancer and lupus nephritis patients. 2007, Anais.. São Paulo: ABCF, 2007. . Acesso em: 20 maio 2024.APA
Fernandes, B. J. D., Silva, C. de M., Marques, M. P., Matthes, Â. do C. S., Andrade, J. M. de, Silva, L. M. da, et al. (2007). Determination of cyclophosphamide enantiomers in plasma by lc-ms/ms: application to pharmacokinetics in breast cancer and lupus nephritis patients. In Abstract. São Paulo: ABCF.NLM
Fernandes BJD, Silva C de M, Marques MP, Matthes  do CS, Andrade JM de, Silva LM da, Donadi EA, Lanchote VL. Determination of cyclophosphamide enantiomers in plasma by lc-ms/ms: application to pharmacokinetics in breast cancer and lupus nephritis patients. Abstract. 2007 ;[citado 2024 maio 20 ]Vancouver
Fernandes BJD, Silva C de M, Marques MP, Matthes  do CS, Andrade JM de, Silva LM da, Donadi EA, Lanchote VL. Determination of cyclophosphamide enantiomers in plasma by lc-ms/ms: application to pharmacokinetics in breast cancer and lupus nephritis patients. Abstract. 2007 ;[citado 2024 maio 20 ]